technology prnewswire_all 6/4/2026 0 views

Mammotome Expands Access to Innovative Breast Biopsy Site Marker

Securing this CE mark expands access to the HydroMARK™ Plus markers across Europe, combining proprietary hydrogel technology with features designed to support marker stability and visibility in breast care. QUICKBORN, Germany, June 4, 2026 /PRNewswire/ -- Mammotome, a Danaher company and...
View original →